SCHEMBL7465016

SCHEMBL7465016

Oc1cnccc1-c1ccccc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RPS6KA3 P51812 3/20 0.54
ALDH1A1 P00352 2/20 0.54
HPGD P15428 1/20 0.54
BCL2L1 Q07817 1/20 0.54
HSD17B10 Q99714 1/20 0.54
BACE1 P56817 1/20 0.50
TNF P01375 1/20 0.48
ALOX5 P09917 1/20 0.48
NOTUM Q6P988 1/20 0.46
CYP1A2 P05177 4/20 0.45
CYP3A4 P08684 4/20 0.45
CYP2A6 P11509 4/20 0.45
CYP2E1 P05181 3/20 0.45
CYP2C8 P10632 3/20 0.45
CYP2D6 P10635 3/20 0.45
CYP2C9 P11712 3/20 0.45
CYP2B6 P20813 3/20 0.45
CYP2C19 P33261 3/20 0.45
FGFR1 P11362 2/20 0.43
AURKA O14965 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30732664 0.87 CYP2A6 (0.58) RPS6KA3ALDH1A1HPGDHSD17B10CYP1A2
SCHEMBL22236422 0.81 RPS6KA3 (0.50) RPS6KA3MAOAMAOB
SCHEMBL29153269 0.81 RPS6KA3 (0.70) RPS6KA3ALOX5CYP3A4SLC22A12
SCHEMBL31359603 0.80 ALDH1A1 (0.57) RPS6KA3ALDH1A1HPGDBCL2L1HSD17B10
SCHEMBL12023184 0.80 IDO1 (0.48) RPS6KA3ALDH1A1HPGDBCL2L1HSD17B10
SCHEMBL21692148 0.79 RPS6KA3 (0.59) RPS6KA3ALDH1A1TNFNOTUMCYP1A2
SCHEMBL8716812 0.79 RPS6KA3 (0.65) RPS6KA3ALDH1A1TNFNOTUMCYP1A2
SCHEMBL21692174 0.79 RPS6KA3 (0.59) RPS6KA3ALDH1A1TNFNOTUMCYP1A2
SCHEMBL6160894 0.79 RPS6KA3 (0.57) RPS6KA3ALDH1A1HPGDHSD17B10BACE1
SCHEMBL28114956 0.77 RPS6KA3 (0.62) RPS6KA3ALDH1A1HPGDHSD17B10CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113009122-B Methods and systems for determining the risk of autism spectrum disorder 美国控股实验室公司 2025-01-17 CN disclosed
EP-0944626-A4 TROPANE DERIVATIVES AND METHOD FOR THEIR SYNTHESIS UNIV GEORGETOWN (US) 2002-09-04 EP disclosed
US-6350758-B1 NOVEL ANALOGS OF COCAINE, ENHANCED ANALGESIC AND/OR VASOCONSTRICTIVE PROPERTIES, INHIBIT THE UPTAKE OF DOPAMINE OR SEROTONIN SO USEFUL FOR TREATING PARKINSON'S DISEASE, DEPRESSION, OR OBESITY, TREATING COCAINE ABUSE, COCAINE GEORGETOWN UNIVERSITY 2002-02-26 US disclosed
EP-0944626-A1 TROPANE DERIVATIVES AND METHOD FOR THEIR SYNTHESIS GEORGETOWN UNIVERSITY (US) 1999-09-29 EP disclosed
WO-1998024788-A1 TROPANE DERIVATIVES AND METHOD FOR THEIR SYNTHESIS GEORGETOWN UNIVERSITY (US) 1998-06-11 WO disclosed